These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35947290)

  • 1. Strongylopus grayii tadpole blastema extract exerts cytotoxic effects on embryonal rhabdomyosarcoma cells.
    Harrison V; Khan SF; Damerell V; Bleloch J; ArulJothi KN; Sinkala M; Lennard K; Mulder N; Calder B; Blackburn J; Prince S
    In Vitro Cell Dev Biol Anim; 2022 Sep; 58(8):679-692. PubMed ID: 35947290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
    Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G
    Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.
    Megiorni F; Gravina GL; Camero S; Ceccarelli S; Del Fattore A; Desiderio V; Papaccio F; McDowell HP; Shukla R; Pizzuti A; Beirinckx F; Pujuguet P; Saniere L; der Aar EV; Maggio R; De Felice F; Marchese C; Dominici C; Tombolini V; Festuccia C; Marampon F
    J Hematol Oncol; 2017 Oct; 10(1):161. PubMed ID: 28985758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase Cδ-4 (PLCδ4) Acts as a Nuclear Player to Influence Cyclin B Expression in the Embryonal Rhabdomyosarcoma Cell Lines RD and A204.
    Salucci S; Bavelloni A; Versari I; Burattini S; Bavelloni F; Gobbi P; Fanzani A; Codenotti S; Blalock W; Scotlandi K; Faenza I
    Biomolecules; 2024 Sep; 14(9):. PubMed ID: 39334946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice.
    Singh S; Vinson C; Gurley CM; Nolen GT; Beggs ML; Nagarajan R; Wagner EF; Parham DM; Peterson CA
    Am J Pathol; 2010 Oct; 177(4):2055-66. PubMed ID: 20829439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells.
    Huot M; Caron M; Richer C; Djibo R; Najmanovich R; St-Onge P; Sinnett D; Raynal NJM
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):845-856. PubMed ID: 34331108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53.
    Canner JA; Sobo M; Ball S; Hutzen B; DeAngelis S; Willis W; Studebaker AW; Ding K; Wang S; Yang D; Lin J
    Br J Cancer; 2009 Sep; 101(5):774-81. PubMed ID: 19707204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
    van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
    Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal adhesion kinase (FAK) phosphorylation is a key regulator of embryonal rhabdomyosarcoma (ERMS) cell viability and migration.
    Al-Ghabkari A; Qasrawi DO; Alshehri M; Narendran A
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1461-1469. PubMed ID: 31006845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining an embryonal rhabdomyosarcoma endotype.
    Ricker CA; Crawford K; Matlock K; Lathara M; Seguin B; Rudzinski ER; Berlow NE; Keller C
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma.
    Di Rocco A; Camero S; Benedetti A; Lozanoska-Ochser B; Megiorni F; Marchese C; Stramucci L; Ciccarelli C; Bouché M; Bossi G; Marampon F; Zani BM
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35801577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anlotinib treatment for rapidly progressing pediatric embryonal rhabdomyosarcoma in the maxillary gingiva: a case report.
    Ding B; Mai B; Liu T; Liu C; Bao H; Hu J; Qian X; Wang S; Ou Q; Dong X; Lei Z; Yan G
    Diagn Pathol; 2024 Oct; 19(1):135. PubMed ID: 39379998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting oxidative stress in embryonal rhabdomyosarcoma.
    Chen X; Stewart E; Shelat AA; Qu C; Bahrami A; Hatley M; Wu G; Bradley C; McEvoy J; Pappo A; Spunt S; Valentine MB; Valentine V; Krafcik F; Lang WH; Wierdl M; Tsurkan L; Tolleman V; Federico SM; Morton C; Lu C; Ding L; Easton J; Rusch M; Nagahawatte P; Wang J; Parker M; Wei L; Hedlund E; Finkelstein D; Edmonson M; Shurtleff S; Boggs K; Mulder H; Yergeau D; Skapek S; Hawkins DS; Ramirez N; Potter PM; Sandoval JA; Davidoff AM; Mardis ER; Wilson RK; Zhang J; Downing JR; Dyer MA;
    Cancer Cell; 2013 Dec; 24(6):710-24. PubMed ID: 24332040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.
    Slemmons KK; Crose LES; Riedel S; Sushnitha M; Belyea B; Linardic CM
    Mol Cancer Res; 2017 Dec; 15(12):1777-1791. PubMed ID: 28923841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence.
    Li JJ; Kovach AR; DeMonia M; Slemmons KK; Oristian KM; Chen C; Linardic CM
    Sci Rep; 2021 Aug; 11(1):16505. PubMed ID: 34389744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine and palmatine inhibit the growth of human rhabdomyosarcoma cells.
    Shinji S; Nakamura S; Nihashi Y; Umezawa K; Takaya T
    Biosci Biotechnol Biochem; 2020 Jan; 84(1):63-75. PubMed ID: 31462179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25-O-acetyl-23,24-dihydro-cucurbitacin F induces cell cycle G2/M arrest and apoptosis in human soft tissue sarcoma cells.
    Lohberger B; Kretschmer N; Bernhart E; Rinner B; Stuendl N; Kaltenegger H; Kahl S; Bauer R; Leithner A
    J Ethnopharmacol; 2015 Apr; 164():265-72. PubMed ID: 25701753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma.
    Vleeshouwer-Neumann T; Phelps M; Bammler TK; MacDonald JW; Jenkins I; Chen EY
    PLoS One; 2015; 10(12):e0144320. PubMed ID: 26636678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of standard chemotherapy on tumor growth and regulation of multidrug resistance genes and proteins in childhood rhabdomyosarcoma.
    Seitz G; Warmann SW; Vokuhl CO; Heitmann H; Treuner C; Leuschner I; Fuchs J
    Pediatr Surg Int; 2007 May; 23(5):431-9. PubMed ID: 17211591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of a regenerative microenvironment in skeletal muscle is sufficient to induce embryonal rhabdomyosarcoma in p53-deficient mice.
    Camboni M; Hammond S; Martin LT; Martin PT
    J Pathol; 2012 Jan; 226(1):40-9. PubMed ID: 21915858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.